key: cord-0919180-cvqha6ss authors: England, Bryant R.; Barber, Claire E.H.; Bergman, Martin; Ranganath, Veena K.; Suter, Lisa G.; Michaud, Kaleb title: Brief Report: Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits date: 2020-08-19 journal: Arthritis Care Res (Hoboken) DOI: 10.1002/acr.24429 sha: a63753ad8a456c7f14964879088919dd7ad93b14 doc_id: 919180 cord_uid: cvqha6ss OBJECTIVE: To provide guidance on the implementation of recommended American College of Rheumatology (ACR) rheumatoid arthritis (RA) disease activity and functional status assessment measures in telehealth settings. METHODS: An expert panel was assembled from the recently convened ACR RA disease activity and functional status measures working groups to summarize strategies for implementation of ACR recommended RA disease activity (Clinical Disease Activity Index [CDAI], 28‐joint Disease Activity Score [DAS28‐ESR/CRP], Patient Activity Scale [PAS‐II], Simplified Disease Activity Index [SDAI], Routine Assessment of Patient Index Data 3 [RAPID3]) and functional status (Health Assessment Questionnaire‐II [HAQ‐II], Multidimensional Health Assessment Questionnaire [MDHAQ], PROMIS physical function 10‐item short form [PROMIS PF‐10]) measures in telehealth settings. RESULTS: Measures composed of patient‐reported items (disease activity: PAS‐II, RAPID3; functional status: HAQ‐II, MDHAQ, PROMIS PF‐10) require minimal modification for use in telehealth settings. Measures requiring formal joint counts (CDAI, DAS28‐ESR/CRP, and SDAI) can be calculated using patient‐reported swollen and tender joint counts. When the feasibility of lab testing is limited, CDAI can be used in place of the SDAI and scoring modifications of the DAS28‐ESR/CRP without the acute phase reactant are available. Assessment of the validity of these modifications is limited. Implementation of these measures can be facilitated by electronic health record collection, mobile applications, and provider/staff administration during telehealth visits. CONCLUSIONS: ACR recommended RA disease activity and functional status measures can be adapted for use in telehealth settings to support high‐quality clinical care. Research is needed to better understand how telehealth settings may impact the validity of these measures. The COVID-19 pandemic has increased the number of telehealth visits in rheumatology through telephone or videoconferencing in a synchronous or asynchronous manner. Many logistical challenges accompany the use of telehealth, including the regular assessment of RA disease activity and functional status that are central to RA management. The American College of Rheumatology (ACR) recently provided updated recommendations on RA disease activity measures and initial recommendations on functional status measures to support high-quality clinical care for routine clinical settings (1, 2) . This guidance has been used to inform quality measures on periodic assessment of disease activity and functional status assessment for providers who report through the Merit-Based Incentive System (MIPS). To support the assessment of RA disease activity and functional status in telehealth settings, the ACR convened a working group to provide strategies for adopting the recommended RA disease activity and functional status measures for telehealth settings. The ACR convened an expert panel from the prior RA disease activity and functional status measures working groups (1, 2) . The recommended RA disease activity measures were the Clinical Disease Activity Index (CDAI), 28-joint Disease Activity Score (DAS28-ESR/CRP), Patient Activity Scale (PAS-II), Simplified Disease Activity Index (SDAI), and Routine Assessment of Patient Index Data 3 (RAPID3), while the recommended functional status assessment measures were the Health Assessment Questionnaire-II (HAQ-II), Multidimensional Health Assessment Questionnaire (MDHAQ), and PROMIS physical function 10-item short form (PROMIS PF-10). We evaluated the feasibility of implementation of the recommended functional status and disease activity measures and provided strategies for modification (if required) and use in telehealth settings to support patient care. A summary of modifications needed for RA disease activity and functional status measures for telehealth use is provided in Table 1 . The measures are recommended to be incorporated in routine practice with the same measures being utilized over time for a given patient and collection Accepted Article occurring at most visits. Minimal standards for reporting on disease activity and functional status are described in the ACR endorsed performance measures used in the MIPS program (see Table 1 footnote). The 2019 ACR recommendations for disease activity and functional status included several entirely patient-reported measures that do not require substitution or modification of any components, thus retaining their original psychometric properties as summarized in the initial reports (1, 2) . These measures include the PAS-II and RAPID3 for RA disease activity and all recommended functional status assessment measures including the HAQ-II, MDHAQ, and PROMIS PF-10. Measures requiring clinician assessments for tender and swollen joint counts and/or physician global scores are not feasible in their original operationalization in a telehealth setting but can be modified for use. The CDAI, DAS28-ESR/CRP, and SDAI all traditionally require provider assessed swollen and tender joint counts. In place of provider joint counts, patient-reported joint counts may be substituted. While several studies have found moderate to strong correlations between patient and provider joint counts and patient and provider-derived composite disease activity scores (3) (4) (5) (6) , there are important caveats to the use of patient joint counts. First, most studies have incorporated baseline in-person training for conducting patient joint counts and found training to improve agreement with provider joint counts (6) . Second, there is less agreement between patients and providers in the assessment of swollen joints compared to tender joint counts and for the assessment of smaller joints compared to larger joints (4) (5) (6) . Finally, while group differences in RA disease activity scores using patient vs. provider joint counts are typically small, there may be larger variability at the individual patient level. This individual variability may be related to disease activity level, RA disease duration, pain, disability, education level, health literacy, and language barriers (3) (4) (5) (6) . Provider global assessments included in the CDAI and SDAI may be collected as usual, though the authors recognize that the validity of the provider global assessment may be impacted by the use of telehealth. Laboratory testing for the measurement of the ESR or CRP is required for the DAS28-ESR/CRP and SDAI. The feasibility of obtaining laboratory testing in conjunction with telehealth varies and may be problematic. Many patients are receiving disease-modifying anti-rheumatic drugs that require regular laboratory monitoring and obtaining the ESR or CRP with this testing may be feasible. For others not receiving regular laboratory testing, those lacking access to a laboratory, or for those who consider the risk of SARS-CoV-2 exposure too great to obtain laboratory testing, the CDAI (calculated using patient reported tender and swollen joint counts) could be used in place of Accepted Article the SDAI and the DAS28-ESR/CRP may be scored without the acute phase reactant but with an added patient pain visual analog scale (7) . The DAS28 without acute phase reactants has not undergone the same validation as the DAS28-ESR/CRP, and whether alternative disease activity state thresholds may improve agreement with the DAS28-ESR/CRP, such as those proposed for the DAS28-CRP, is unknown. While some measures, or components of measures, do not need modification, the processes for collecting the components of these measures, particularly patient-reported components, will change for many practices. The most significant factors for optimizing the collection of patientreported measures are the technical capabilities of the patients, providers, and electronic medical record (EMR) vendors. In place of paper forms, patient-reported items can be completed by patients prior to their telehealth visit directly within some EMRs through a patient portal. In these situations, patients are provided a notification via email prior to their appointment to complete these measures, which are then reviewed during their medical appointment with their provider. Advantages of EMRbased measure collection are minimal to no process change for telehealth encounters and the integration of the measures into the medical record with the ability to track and trend measures over time. Disadvantages may include challenges in completing surveys for individuals with lack of computer access, limited computer literacy, and language barriers as well as additional support staff may be required for administration (8) . For health systems/clinics without patient portals capable of electronically capturing patient reported measures from patients directly, providers or clinic staff may administer the surveys during the telehealth visit. The advantage of provider/staff administration during the visit is greater support for those with lower literacy in completion of the forms and likely higher provider understanding of the disease impact on patients through discussion of responses. The main disadvantages are the added time requirements to encounters for providers and/or added administrative/staff burden. Lastly, measures can be obtained by mailings or electronic capture outside of the EMR. Mailed paper forms can be prefilled by the patient and recorded during the telehealth visit or mailed back to the provider. While this may lower the burden of provider/staff time during an encounter, this increases the possibility of lower response rates and requires administrative support for mailing and processing the measures. Smartphone and web-based apps can be used by the patient and/or the provider to collect these measures electronically during the telehealth visit or at regular intervals and This article is protected by copyright. All rights reserved summarized during the telehealth visit (8) . Integration of mobile apps into health records is an active area of study (9) . Scoring of RA disease activity and functional status measures can be facilitated by the ACR Clinical Practice Guidelines and Criteria App as well as on the ACR website (https://www.rheumatology.org/Practice-Quality/Clinical-Support/Quality-Measurement/Disease-Activity-Functional-Status-Assessments) when not available within the EMR. A summary of strategies and potential barriers for telehealth data collection are listed in Table 2 . While workflows vary between clinics and within clinics over time, successful collection of these measures can be facilitated by developing and assessing the performance of standard clinic workflows, educating staff and patients, and addressing patient health literacy and language barriers The current COVID-19 pandemic has heightened the need to care for patients with RA in an increasingly virtual environment. Following the announcement of the public health emergency, many rheumatology clinics were closed or had only limited face-to-face appointments due to social distancing restrictions and health system surge capacity planning. Therefore, it became necessary to deploy telehealth clinics using telephone or videoconference technology rapidly to ensure continuity of care. The routine collection and use of disease activity and functional status measures for highquality RA care has been established as part of face-to-face encounters. While telehealth encounters have replaced face-to-face visits, the use of disease activity and functional status measures remain highly valuable for the management of RA during these uncertain times. Here we have detailed approaches to facilitate the use of ACR recommended RA disease activity and functional status measures in conjunction with telehealth encounters. All ACR recommended RA disease activity (CDAI, DAS28-ESR/CRP, PAS-II, RAPID-3, SDAI) and functional status measures (HAQ-II, MDHAQ, PROMIS PF-10) can be adapted for use in telehealth settings using the provided modifications (Table 1) . These recommendations on modification of RA disease activity and functional status measures for telehealth settings were focused on measures recently recommended by the ACR because these measures were selected as those with the best validity and feasibility for routine use. Adapting these measures for telehealth clearly affects feasibility and, depending on the modifications needed to score these measures, may also affect the validity. Alterations to the validity of these measures is anticipated to be greatest for substituting patient-reported joint counts for provider joint Information National Trends Survey found only 31% of the general public utilized patient portals in 2018, with females, Caucasians, and those with higher education levels more likely to use patient portals (11) . If the EMR is not compatible or IT infrastructure is not available, changing vendors or building this infrastructure will take substantial time, effort, and monetary commitment initially and for continued IT maintenance. The other methods of measure collection will require additional provider and/or administrator/clinical staff time. This may be compounded if provider joint counts are replaced with patient joint counts at the same telehealth encounter, necessitating patient education for the proper completion of these joint counts. Although most studies evaluating patient joint counts have utilized in person training, patient resources and optimal training processes have not been established. The development of patient resources describing the conduct of patient joint counts as well as the process and importance of regularly monitoring disease activity and physical function should be a priority to facilitate virtual care. Furthermore, when initiating telehealth encounters, providers may already spend a significant amount of time in IT support (personally or with the patient) rather than providing direct care. A limitation of this work is that we did not conduct a new literature search on telehealth tools for the collection of disease activity or functional status measures, which was beyond the scope of this work. This article is protected by copyright. All rights reserved Beyond the pandemic, the use of the telehealth for RA care may be already happening in some areas due to the geography, climate, transportation availability, and workforce shortages (12) . It is likely that post-pandemic telehealth use may increase and may help address rheumatology workforce challenges facing many regions (13) . For example, telehealth may support safe remote monitoring of stable RA patients allowing a redistribution of rheumatology resources to support urgent cases and new consultations. The virtual delivery of patient-reported outcomes has also been used to support treat-to-target initiatives in RA care and has been shown to be non-inferior to routine care in a randomized controlled trial setting (14) . Furthermore, electronic collection of patientreported outcomes using EMRs or custom platforms or smartphone apps may support quality improvement and research initiatives. Virtual care complimented by electronic PRO collection may also be acceptable and even preferred by some patients due to social and work obligations. For example, qualitative studies have shown that telehealth follow-up is acceptable to many patients with RA although strategies may need to be developed to better assist some individuals requiring additional supports to adapt (15) . Challenges exist in this environment such as supporting patients and families with lower computer literacy and those where English is a second language. Additionally, it remains uncertain what is the optimal balance between telehealth and face-to-face encounters for long-term RA management. In summary, the challenges of the pandemic have accelerated changes in the way we deliver care and invited many opportunities to provide more patient-centered and flexible care. To support high-quality telehealth care for patients with RA in this new environment, we have described This article is protected by copyright. All rights reserved American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures Patients with Rheumatoid Arthritis Acquire Sustainable Skills for Home Monitoring: A Prospective Dual-country Cohort Study (ELECTOR Clinical Trial I) Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group level Value of self-performed joint counts in rheumatoid arthritis patients near remission Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research Mobile Apps for Rheumatoid Arthritis: Opportunities and Challenges Providing 'the bigger picture': benefits and feasibility of integrating remote monitoring from smartphones into the electronic health record Accepted Article This article is protected by copyright. All rights reserved 10 Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID-19 Pandemic. ACR Open Rheumatol Use of Patient Portals of Electronic Health Records Remains Low From Factors associated with use of telemedicine for follow-up of rheumatoid arthritis American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce Tele-Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled Trial Experiences With Telehealth Followup in Patients With Rheumatoid Arthritis: A Qualitative Interview Study The authors wish to recognize the following American College of Rheumatology staff who facilitated this project: Amy Turner, Rachel Myslinski, Regina Parker, Robin Lane, and Tracy Johansson. This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved